Restricted accessResearch articleFirst published online 2013-3
Implantation of Resorbable Gentamicin Sponges in Addition to Irrigation and Debridement in 34 Patients with Infection Complicating Total Hip Arthroplasty
We evaluated a prosthesis-retaining treatment protocol for prosthetic joint infection in patients presenting at a mean of 116 days (range 10-1216 days) after primary arthroplasty. Our regime involved irrigation and debridement followed by implantation of biodegradable gentamicin loaded sponges which do not require removal after implantation.
Of 34 patients with a deep infection after total hip arthroplasty, Twenty-five were treated successfully, with a mean follow-up of 35 months. There were no permanent complications. This success rate is comparable to earlier studies. Early initiation of treatment demonstrated a tendency for better results, and late chronic infections had a worse outcome. Because the sponges are degradable, a number of further surgical procedures were avoided.
ChenW.S., FuT.H., WangJ.W.Two-stage reimplantation of infected hip arthroplasties.Chang Gung Med J.2009; 32(2): 188–97.
6.
GiulieriS.G., GraberP., OchsnerP.E., ZimmerliW.Management of infection associated with total hip arthroplasty according to a treatment algorithm.Infection.2004; 32(4): 222–8.
7.
LanglaisF.Can we improve the results of revision arthroplasty for infected total hip replacement?J Bone Joint Surg Br.2003; 85(5): 637–40.
8.
SorianoA., GarciaS., BoriG.. Treatment of acute post-surgical infection of joint arthroplasty.Clin Microbiol Infect.2006; 12(9): 930–3.
9.
AboltinsC.A., PageM.A., BuisingK.L.. Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid.Clin Microbiol Infect.2007; 13(6): 586–91.
10.
WalenkampG.H.Joint prosthetic infections: a success story or a continuous concern?Acta Orthop.2009; 80(6): 629–32.
11.
ByrenI., BejonP., AtkinsB.L.. One hundred and twelve infected arthroplasties treated with 'DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome.J Antimicrob Chemother.2009; 63(6): 1264–71.
12.
CrockarellJ.R., HanssenA.D., OsmonD.R., MorreyB.F.Treatment of infection with debridement and retention of the components following hip arthroplasty.J Bone Joint Surg Am.1998; 80(9): 1306–13.
13.
KrasinE., GoldwirthM., HemoY., GoldA., HerlingG., OtremskiI.Could irrigation, debridement and antibiotic therapy cure an infection of a total hip arthroplasty?J Hosp Infect.2001; 47(3): 235–8.
14.
MarculescuC.E., BerbariE.F., HanssenA.D.. Outcome of prosthetic joint infections treated with debridement and retention of components.Clin Infect Dis.2006; 42(4): 471–8.
15.
MeehanA.M., OsmonD.R., DuffyM.C., HanssenA.D., KeatingM.R.Outcome of penicillin-susceptible streptococcal prosthetic joint infection treated with debridement and retention of the prosthesis.Clin Infect Dis.2003; 36(7): 845–9.
16.
TrebseR., PisotV., TrampuzA.Treatment of infected retained implants.J Bone Joint Surg Br.2005; 87(2): 249–56.
17.
TsukayamaD.T., EstradaR., GustiloR.B.Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections.J Bone Joint Surg Am.1996; 78(4): 512–23.
18.
DiefenbeckM., MückleyT., HofmannG.O.Prophylaxis and treatment of implant-related infections by local application of antibiotics.Injury.2006; 37 Suppl 2: S95–104.
19.
RuszczakZ., FriessW.Collagen as a carrier for on-site delivery of antibacterial drugs.Adv Drug Deliv Rev.2003; 55(12): 1679–98.
20.
WalenkampG.H.Gentamicin PMMA beads and other local antibiotic carriers in two-stage revision of total knee infection: a review.J Chemother.2001; 13 Spec No 1(1): 66–72.
21.
NelsonC.L., EvansR.P., BlahaJ.D., CalhounJ., HenryS.L., PatzakisM.J.A comparison of gentamicin-impregnated polymethylmethacrylate bead implantation to conventional parenteral antibiotic therapy in infected total hip and knee arthroplasty.Clin Orthop Relat Res.1993; (295): 96–101.
22.
SwieringaA.J., GoosenJ.H., JansmanF.G., TulpN.J.In vivo pharmacokinetics of a gentamicin-loaded collagen sponge in acute periprosthetic infection: serum values in 19 patients.Acta Orthop.2008; 79(5): 637–42.
23.
WalenkampG.H., VreeT.B., van RensT.J.Gentamicin-PMMA beads. Pharmacokinetic and nephrotoxicological study.Clin Orthop Relat Res.1986; (205): 171–83.
24.
SalgadoC.D., DashS., CanteyJ.R., MarculescuC.E.Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections.Clin Orthop Relat Res.2007; 461: 48–53.
25.
ChoongP.F., DowseyM.M., CarrD., DaffyJ., StanleyP.Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampinbased regimen.Acta Orthop.2007; 78(6): 755–65.
26.
SharmaD., DouglasJ., CoulterC., WeinrauchP., CrawfordR.Microbiology of infected arthroplasty: implications for empiric peri-operative antibiotics.J Orthop Surg (Hong Kong).2008; 16(3): 339–42.
27.
HanssenA.D., SpangehlM.J.Treatment of the infected hip replacement.Clin Orthop Relat Res.2004; (420): 63–71.
28.
RodriguezD., PigrauC., EubaG.. Acute hematogenous prosthetic joint infection: prospective evaluation of medical and surgical management.Clin Microbiol Infect.2010; 16(12): 1789–95.
29.
GillespieW.J.Prevention and management of infection after total joint replacement.Clin Infect Dis.1997; 25(6): 1310–7.
30.
KaltsasD.S.Infection after total hip arthroplasty.Ann R Coll Surg Engl.2004; 86(4): 267–71.
